LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease

Neurogenetics

Volumn 11, Issue 4, 2010, Pages 401-408

  Vilariño Güell, Carles ^a   Wider, Christian ^a,b   Ross, Owen A ^a   Jasinska Myga, Barbara ^a,c   Kachergus, Jennifer ^a   Cobb, Stephanie A ^a   Soto Ortolaza, Alexandra I ^a   Behrouz, Bahareh ^a   Heckman, Michael G ^d   Diehl, Nancy N ^d   Testa, Claudia M ^e   Wszolek, Zbigniew K ^d   Uitti, Ryan J ^d   Jankovic, Joseph ^f   Louis, Elan D ^g,h,i   Clark, Lorraine N ^h   Rajput, Alex ^j   Farrer, Matthew J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d MAYO CLINIC   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Parkinson's Disease Center   (United States)

^g Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^h NONE   (United States)

ⁱ NONE   (United States)

^j ROYAL UNIVERSITY HOSPITAL   (Canada)

more..

Author keywords

Essential tremor; Genetic association; LINGO1; LINGO2; Parkinson disease

Indexed keywords

ADOLESCENT; ADULT; AGED; AMERICAN INDIAN; ARTICLE; CHILD; CONTROLLED STUDY; ESSENTIAL TREMOR; FEMALE; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LEUCINE RICH REPEAT AND IG DOMAIN CONTAINING 1 GENE; LEUCINE RICH REPEAT AND IG DOMAIN CONTAINING 2 GENE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARALOGY; PARKINSON DISEASE; PRIORITY JOURNAL; SCHOOL CHILD; SEGREGATION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 78650039010     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-010-0241-x     Document Type: Article

References (32)

1. de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, BaldereschiM, Fratiglioni L, Lobo A,Martinez-Lage J, Trenkwalder C, Hofman A (2000) Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 54:S21-S23
2. Louis ED, Thawani SP, Andrews HF (2009) Prevalence of essential tremor in a multiethnic, community-based study in northern Manhattan, New York, NY. Neuroepidemiology 32:208-214
3. Rajput AH, Birdi S (1997) Epidemiology of Parkinson's disease. Parkinsonism Relat Disord 3:175-186
4. Sur H, Ilhan S, Erdogan H, Ozturk E, Tasdemir M, Boru UT (2009) Prevalence of essential tremor: a door-to-door survey in Sile, Istanbul, Turkey. Parkinsonism Relat Disord 15:101-104
5. Louis ED, Faust PL, Vonsattel JP, Honig LS, Rajput A, Robinson CA, Pahwa R, Lyons KE, Ross GW, Borden S, Moskowitz CB, Lawton A, Hernandez N (2007) Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 130:3297-3307
6. Dickson DW (2001) Alpha-synuclein and the Lewy body disorders. Curr Opin Neurol 14:423-432
7. Benito-Leon J, Louis ED, Bermejo-Pareja F (2009) Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study. J Neurol Neurosurg Psychiatry 80:423-425
8. Isaias IU, Canesi M, Benti R, Gerundini P, Cilia R, Pezzoli G, Antonini A (2008) Striatal dopamine transporter abnormalities in patients with essential tremor. Nucl Med Commun 29:349-353
9. Vilarino-Guell C, Ross OA, Wider C, Jasinska-Myga B, Cobb SA, Soto-Ortolaza AI, Kachergus JM, Keeling BH, Dachsel JC, Melrose HL, Behrouz B, Wszolek ZK, Uitti RJ, Aasly JO, Rajput A, Farrer MJ (2009) LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord. doi:10.1016/j.parkreldis.2009.08.006, Epub
10. Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, Sweigard H, Engber T, Pepinsky B, Yang L, Beal MF, Mi S, Isacson O (2007) Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc Natl Acad Sci USA 104:14430-14435
11. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, LevesqueM, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB (2004) LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7:221-228
12. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB (2005) LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8:745-751
13. Li W, Walus L, Rabacchi SA, Jirik A, Chang E, Schauer J, Zheng BH, Benedetti NJ, Liu BP, Choi E, Worley D, Silvian L, Mo W, Mullen C, Yang W, Strittmatter SM, Sah DW, Pepinsky B, Lee DH (2004) A neutralizing anti-Nogo66 receptor monoclonal antibody reverses inhibition of neurite outgrowth by central nervous system myelin. J Biol Chem 279:43780-43788
14. Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, Yuan Q, Wong WM, Wang L, Su H, Chu TH, Guo J, Zhang W, So KF, Pepinsky B, Shao Z, Graff C, Garber E, Jung V, Wu EX, Wu W (2007) LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 13:1228-1233
15. Shao Z, Browning JL, Lee X, Scott ML, Shulga-Morskaya S, Allaire N, Thill G, Levesque M, Sah D, McCoy JM, Murray B, Jung V, Pepinsky RB, Mi S (2005) TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 45:353-359
16. Carim-Todd L, Escarceller M, Estivill X, Sumoy L (2003) LRRN6A/LERN1 (leucine-rich repeat neuronal protein 1), a novel gene with enriched expression in limbic system and neocortex. Eur J NeuroSci 18:3167-3182
17. Ji B, Li M, Wu WT, Yick LW, Lee X, Shao Z, Wang J, So KF, McCoy JM, Pepinsky RB, Mi S, Relton JK (2006) LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol Cell Neurosci 33:311-320
18. Mi S, Sandrock A, Miller RH (2008) LINGO-1 and its role in CNS repair. Int J Biochem Cell Biol 40:1971-1978
19. StefanssonH, Steinberg S, Petursson H,Gustafsson O, Gudjonsdottir IH, Jonsdottir GA, Palsson ST, Jonsson T, Saemundsdottir J, Bjornsdottir G, Bottcher Y, Thorlacius T, Haubenberger D, Zimprich A, Auff E, Hotzy C, Testa CM, Miyatake LA, Rosen AR, Kristleifsson K, Rye D, Asmus F, Schols L, Dichgans M, Jakobsson F, Benedikz J, Thorsteinsdottir U, Gulcher J, Kong A, Stefansson K (2009) Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 41:277-279
20. Tan EK, Teo YY, Prakash KM, Li R, Lim HQ, Angeles D, Tan LC, Au WL, Yih Y, Zhao Y (2009) LINGO1 variant increases risk of familial essential tremor. Neurology 73:1161-1162
21. Haines BP, Rigby PW (2008) Expression of the Lingo/LERN gene family during mouse embryogenesis. Gene Expr Patterns 8:79-86
22. Homma S, Shimada T, Hikake T, Yaginuma H (2009) Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. Gene Expr Patterns 9:1-26
23. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33-39
24. Louis ED, Ford B, Lee H, Andrews H, Cameron G (1998) Diagnostic criteria for essential tremor: a population perspective. Arch Neurol 55:823-828 (Pubitemid 28265699)
25. Mata IF, Kachergus JM, Taylor JP, Lincoln S, Aasly J, Lynch T, Hulihan MM, Cobb SA, Wu RM, Lu CS, Lahoz C, Wszolek ZK, Farrer MJ (2005) Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 6:171-177 (Pubitemid 41720888)
26. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
27. Lin PI, Vance JM, Pericak-Vance MA, Martin ER (2007) No gene is an island: the flip-flop phenomenon. Am J Hum Genet 80:531-538
28. Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJ, Brown J, Ban M, Spillantini MG, Compston A, Burn DJ, Chinnery PF, Barker RA, Sawcer SJ (2007) Tau and alphasynuclein in susceptibility to, and dementia in, Parkinson's disease. Ann Neurol 62:145-153
29. Wider C, Vilarino-Guell C, Jasinska-Myga B, Heckman M, Soto- Ortolaza AI, Cobb SA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA (2009) Association of the MAPT locus with Parkinson's disease. Eur J Neurol. doi:10.1111/ j.1468-1331.2009.02847.x, Epub
30. Peuralinna T, Oinas M, Polvikoski T, Paetau A, Sulkava R, Niinisto L, Kalimo H, Hernandez D, Hardy J, Singleton A, Tienari PJ, Myllykangas L (2008) Neurofibrillary tau pathology modulated by genetic variation of alpha-synuclein. Ann Neurol 64:348-352
31. Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wullner U, Goldwurm S, PellecchiaMT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, Poewe W, Wenning GK, Hardy JA, Singleton AB, Gasser T (2009) SNCAvariants are associated with increased risk for multiple system atrophy. Ann Neurol 65:610-614
32. Farrer MJ (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7:306-318